Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds

Reuters – Friday, April 25, 2025
By Maggie Fick

LONDON, April 25 (Reuters) – A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on, a report commissioned by the industry’s U.S. trade group and reviewed by Reuters shows.

Click here to read the entire article.